Hemodynamic responses to volume loading with infusion of dextran-40 and myocardial stimulation with isoproterenol in 23 patients in shock from hemorrhage, trauma, or sepsis, and 10 healthy controls were studied. Responses of the control were moderate to dextran and marked to isoproterenol. Shock patients were divided into three groups according to the response of the cardiac index to dextran-40: group I, > 50% increase; group II, 15 to 50% increase; group III, < 15% increase or a decrease. The central venous pressure of patients who responded to dextran (group I) generally rose moderately and that of those who failed to respond (group III) increased without improvement of cardiac index or stroke index, suggesting myocardial failure. Group II showed cardiac improvement at the expense of marked increase in venous pressure, suggesting relative cardiac insufficiency.
factor in survival in their experiments. On the other hand, Crowell and Guyton3 reported progressive myocardial failure as a cause of irreversibility; Rothe and Selkurt4 believed cardiac failure contributed to death in experimental hemorrhagic shock.
Experimental evidence favors the concept that cardiac function is decreased during shock and that cardiac failure contributes to mortality only after prolonged and severe oligemia.4 6 However, some data suggest that both functional' and histopathological7 changes occur early. Microscopic lesions were observed in the heart as early as 15 minutes after onset of hypotension; these histopathological changes were related to the severe tachycardia during and after shock.7' 8 The capacity of the cardiac contractile mechanism was maintained consistently up to the Although experimental evidence suggests that cardiac failure occurs only late in shock, most of the reported experiments lasted only a few hours. In the present clinical series as well as other reported series,10 shock may be considerably more prolonged, particularly shock arising from sepsis.
The present study reports the response to volume loading and isoproterenol infusion in a series of 23 patients in shock. None of the patients had previous history or evidence of heart disease. Cardiovascular function was evaluated by the response to intravenous administration of low-viscosity, low-molecular weight dextran (dextran-40*). Previous studies from this laboratory have shown that dextran-40 produces rapid and sustained increase in plasma volume, decreased hematocrit, decreased blood viscosity, as well as increased central venous pressure, cardiac output, stroke work and stroke power.11-4 Consistent elevation of central venous pressure after dextran-40 in the absence of heart disease suggested that this agent would produce near maximal volume loading of the heart. The hemodynamic responses to volume loading with the dextran-40 were compared with the responses to the inotropic agent, isoproterenol, which was administered to 12 patients of this series. A type of cardiac function curve was used as a semiqualitative basis for analysis of the response to these two agents. 10 Other evidence of shock included tachycardia, tachypnea, low urine output, peripheral cyanosis, and mental confusion or stupor. The etiological events precipitating the shock state were hemorrhage, trauma, and sepsis in various combinations. Trauma was generally surgically induced; in a number of cases surgical intervention followed penetrating abdominal or thoracic injury. Because of prior antibiotic therapy or a rapid fulminating clinical course, sepsis was not always proven by bacteriological examination. However, gross evidence of contamination at surgery or autopsy and development of major septic complications were taken as evidence of sepsis.
Ten young, healthy subjects, admitted for elective surgery also were studied before and after infusion of dextran-40 under comparable conditions; four were studied before and during infusion of isoproterenol. These observations served as controls for comparison of the cardiovascular responses of shock patients.
Materials and Protocol
A central venus catheter for blood sampling and pressure recording was carefully positioned in or adjacent to the right atrium and a catheter was inserted into a femoral artery percutaneously. The position of the venous catheter was checked by the pressure recording obtained.
Three to six control measurements of cardiac output, together with measurements of systemic arterial and central venous pressures, were recorded. Then 500 ml of a 10% solution of dextran-40 was infused over a 50-minute period. The measurements were repeated at 10-minute intervals during infusion, and subsequently at 15 to 30-minute intervals for several hours after infusion. Either shortly before dextran infusions or at a subsequent period not less than 4 or more than 12 hours, cardiac output and pressures were measured again. Then isoproterenol was infused by slow intravenous drip in a concentration of 4 mg per liter of saline. Cardiovascular measurements were repeated at frequent intervals, particularly at the point of maximum response, which was determined by pulse rate, blood pressure, pulse pressure, and cardiac output. The average dose was approximately 10 jug per minute.
Analytical Methods
Cardiac output was calculated from indicatordilution curves using indocyanine green as the indicator.'5 Approximately 3.5 mg of dye, diluted in 2.42 ml of sterile distilled water, was injected through the central venous catheter, and the time of injection was recorded electrically. Arterial blood was withdrawn by a constant withdrawal syringe through a Gilford photodensitometer, and the dye curve was recorded on a Texas Instrument or multichannel Offner direct writing recorder. A delay of 5 seconds was measured in the catheter system connecting the densitometer to the arterial catheter. This was subtracted from the recorded time of injection for calculation of mean transit times.
Ten, 20, and 30 ,.d of the dye was added to 10 ml aliquots of the patients' blood and analyzed by the same photodensitometric system shortly before or after the measurements were made. Standard optical density concentration curves were obtained; they were approximately linear. Cardiac output, mean transit time, and central blood volume were calculated from the dye curves by means of an LGP digital computer programmed for this purpose. The central blood volume which represents the catheter-to-catheter volume in addition to the blood in the heart and lunes also included the volume of blood in the aorta and parts of the large arterial branches. Total peripheral resistance, stroke index, and left ventricular stroke and minute work were derived from formulas shown in table 2. The reproducibility of repeated measurements in an unstressed patient which include both the variability of the patient and recording system also are shown in table 2. A standard deviation of 5.4% of the mean value for consecutive cardiac output measurements was obtained. The accuracy of derived calculations is somewhat less because of additional, but relatively small, errors involved in obtaining mean arterial and venous pressure measurements.
Results

Clinical Observations
Patients were divided into three groups according to the cardiac output response to dextran-40 (table 1) . Group -,I included 11 patients in whom the cardiac index increased more than 50% after dextran. Group II included five patients, with more than 15% but less than 50% increases in cardiac output over control values. Group III included seven patients in whom no significant change or a decrease in cardiac output was seen after infusion of dextran-40. All but four patients in the series had been in shock for longer than 10 hours. These four patients were in group I. In groups I and II, the etiology of shock was primarily trauma and hemorrhage, but was frequently complicated by sepsis. In four of seven patients of group III, shock arose primarily from sepsis; in only one case was shock attributed to hemorrhage and trauma. Average age was slightly more in groups I and II than in group III; hematocrit readings were similar in the three groups; duration of shock was somewhat longer in group II. There was no significant difference in average duration of shock or blood volume measurements between group I and group III patients. Table 3 summarizes the results for control subjects and shock patients in each group. The values are expressed for the mean control measurements taken immediately before infusion and for the maximum change during or within 1 hour after infusion; in most cases the maximum value was reached at the end of infusion.
Responses to Dextran-40 Control Group
In the control patients, dextran-40 increased Circalation, Volume XXXV, February 1967 cardiac index 25%. This was accompanied by a pronounced rise in central venous pressure and decreased peripheral resistance. Stroke index, left ventricular stroke work, and minute work showed modest but significant increases. Mean arterial pressure and heart rate did not change significantly.
Group I
The initial mean values of cardiac index, and mean arterial and central venous pressures were lowest in this group. Peripheral resistance and central blood volume were within normal limits, and stroke index and left ventricular stroke and minute work were depressed markedly. After infusion of dextran-40, mean cardiac index rose to normal values. Mean arterial pressure increased significantly. Heart rate remained elevated, central venous pressure rose, peripheral resistance decreased, Figure 2 in four patients; it decreased during infusion in fone oathentse bt increased slringht inf th Representative case from group II illustrating the rein one of these, but inreased slightly in the sponse to 500 ml of 10% dextran-40 given to an Representative case from group III illustrating the response to 500 ml of 10% dextran-40 given preoperatively to a 51-year-old man with late perforated peptic ulcer. During early part of infusion, cardiac index (CI), mean arterial pressure (BP), and left ventricular minute work (LVMW) increased. After 300 ml of dextran solution was given, CVP increased markedly while arterial pressure, cardiac index, and work abruptly fell. Cardiac index was restored by isoproterenol (ISOP) infusion which was started at the time indicated by the vertical line on the right.
Although the separation of group I and group II patients is based arbitrarily on quantitative rather than qualitative differences, and therefore open to some question, clearly the patients of group III belong to a different population.
Discussion
The normal heart1F19 as well as the hearts of the control subjects reported on herein is able to tolerate sudden 500-ml volume loads. In the present series, the lack of cardiac index responses to volume loads in seven shock patients and diminished responses in five others suggest limited cardiac functional reserve. In young, healthy control subjects given dextran, Control stroke index values were severely decreased before therapy. These values approached normal in group I and group II patients after volume loading with dextran, but did not change in group III patients. By contrast, stroke index improved in group III patients during infusion of isoproterenol, but did not change in group I or control subjects.
These factors should increase tolerance to volume loading. Although it is possible that shock patients not responding to dextran may have had similar mechanisms operating, severe depression of arterial pressure, stroke index, cardiac work, as well as other factors, may have limited them. Heart rates of shock patients, which were nearly double those of control subjects, suggested that increased sympathetic activity was present.
The marked response to isoproterenol in all patients who failed to respond to volume loading was unexpected, since experimental evidence had suggested that there were already high levels of circulating catecholamines under condition of shock. 22 This may be explained by pharmacological differences between isoproterenol and endogenous catecholamines. Isoproterenol is believed to dilate both resistance and capacitance vessels in the peripheral circulation, while norepinephrine constricts them. 23 Epinephrine is reported to dilate resistance vessels in some areas (skeletal muscle) but constricts capacitance vessels. 23 Conceivably the peripheral effects of both norepinephrine and epinephrine may negate the inotropic effects on the heart by impeding venous return. Furthermore, isoproterenol is more potent in inotropic activity than naturally occurring catecholamines.
Group I patients showed modest or attenuated responses to isoproterenol but marked cardiac index responses to volume loading. This may be interpreted as a failure of venous return to the right heart. The possibility exists that the peripheral effects of isoproterenol may account for the observed cardiovascular responses. However, this view is not favored, because isoproterenol failed to produce significant increases in cardiac output in group I patients whose venous return was thought to be inadequate.
The responses to isoproterenol may be explained by its effect on the heart and pulmonary circulation. In addition to the inotropic action of the heart, it is likely that isoproterenol decreased pulmonary vascular resistance particularly in group III patients. Other agents that reduce pulmonary vascular resistance, as phenoxybenzamine, apparently do not have direct inotropic activity. In a series reported by Wilson and co-workers,24 phenoxybenzamine combined with norepinephrine produced increased cardiac output in a manner similar to that reported here.
Studies on experimental animals have shown that the contractile mechanism of cardiac muscle is normal up to the point of death from hemorrhagic shock.9 Mechanisms linking energy metabolism to the myocardial contractile mechanism may contribute to the defects producing cardiac failure. Recent experiments of Stam and Honig25 have suggested that adrenergic mediators function as the link between energy metabolism and 
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CARDIOVASCULAR FUNCTION IN SHOCK the contractile mechanism, primarily by increasing myofibrillar adenosinetriphosphatase (ATPase) activity. In this respect isoproterenol was considerably more potent than either epinephrine or norepinephrine. Further, optimal adrenergic transmitter activity may be necessary, and moderate norepinephrine depletion may have serious inhibited contractile activity. The failure of the circulation to respond significantly to phenoxybenzamine alone, as reported by Wilson and associates24 and as noted by our group (unpublished data), suggests that the effects of isoproterenol cannot be explained solely on the basis of its effect on the pulmonary circulation. Therefore, increases in cardiac output are largely attributed to direct effects of the adrenergic mediator on the contractile mechanism. The decrease in tissue catecholamines found in chronic heart failure has been ascribed to a failure of normal uptake and binding of these agents26; however, responsiveness to catecholamine stimulation is not decreased, but rather enhanced, after depletion of tissue levels.27 Since ATP is supposed to be the site of binding of catecholamines,28 and since tissue levels of ATP decrease in hypoxia,29 defect in binding and synthesis of catecholamines at the receptor level may also exist in shock. If this is true, then the addition of large amounts of adrenergic neurotransmitter to the circulation of the shock patient may compensate for the decrease in binding capacity and resynthesis at the receptor level and account for the marked increases in cardiac output after isoproterenol.
The relative importance of both cardiac deterioration and peripheral vascular failure as the limiting factors in survival of the shock patient remains unanswered. From this study it is evident that cardiac function was diminished significantly in seven of 23 patients in shock from noncardiogenic causes. Five patients improved and two ultimately survived after continuous isoproterenol infusion for 12 to 24 hours. Hemodynamic functions in patients improved after volume loading; although response to volume therapy suggests Circulation, Volume XXXV, February 1967 the presence of peripheral circulatory failure, restoration of cardiovascular function and complete recovery are more convincing endpoints. Unfortunately, many of these patients succumbed later to multiple complications of their diseases, sepsis being a major contributor. Although there is evidence that plasma expansion and catecholamine infusion may be necessary to maintain the circulation of the shock patient, it is likely that death in most cases may be attributable to many factors other than failure of the circulation.
Conclusions
It is concluded from this study that a significant number of patients in shock from hemorrhage, trauma, and sepsis exhibit signs of cardiac insufficiency. The ability of these hearts to respond to isoproterenol suggests the possibility that depletion or altered metabolism of endogenous catecholamines in part underlies this insufficiency. Furthermore, it is suggested that cardiac insufficiency may contribute to the death of a significant number of patients with severe hemorrhagic and septic shock.
